Skip to main content
Top
Published in: BMC Pediatrics 1/2011

Open Access 01-12-2011 | Research article

Antidepressant and antipsychotic use in an Italian pediatric population

Authors: Antonio Clavenna, Margherita Andretta, Paola Pilati, Maurizio Dusi, Michele Gangemi, Maria Beatrice Gattoni, Giuseppe Lombardo, Leonardo Zoccante, Luigi Mezzalira, Maurizio Bonati

Published in: BMC Pediatrics | Issue 1/2011

Login to get access

Abstract

Background

The safety and effectiveness of psychotropic drug use in the paediatric population is widely debated, in particular because of the lack of data concerning long term effects.
In Italy the prevalence of psychotropic drug prescriptions increased in the early 2000s and decreased afterwards. In such a context, a study with the aim to estimate the incidence and prevalence of psychotropic drug prescription in the paediatric population and to describe diagnostic and therapeutic approaches was performed.

Methods

The study population was composed of 76,000 youths less than 18 years and living in the area covered by the local health unit of Verona, Italy. The data source was the Verona local health unit's administrative prescription database. Prevalence and incidence of antidepressant and/or antipsychotic drug prescriptions in the 2004-2008 period were estimated. Children and adolescents receiving antidepressant and/or antipsychotic drug prescriptions between 1 January 2005 and 31 December 2006 were identified and questionnaires were sent to the prescribers with the aim to collect data concerning diagnostic and therapeutic approaches, and care strategies.

Results

The prevalence of psychotropic drug prescriptions did not change in the 2004-2008 period, while incidence slightly increased (from 7.0 in 2005 to 8.3 per 10,000 in 2008). Between 1 January 2005 and 31 December 2006, 111 youths received at least one psychotropic drug prescription, 91 of whom received antidepressants. Only 28 patients attended child and adolescent psychiatry services. Information concerning diagnostic and therapeutic approaches, and care strategies was collected for 52 patients (47%). Anxiety-depressive syndrome and attention disorders were the diseases for which psychotropic drugs were most commonly prescribed. In all, 75% youths also received psychological support and 20% were prescribed drugs for 2 or more years.

Conclusions

Despite the low drug prescription prevalence, the finding that most children were not cared for by child and adolescent psychiatric services is of concern and calls for a systematic, continuous monitoring of psychopharmacological treatments.
Appendix
Available only for authorised users
Literature
1.
go back to reference Raz A: Perspectives on the efficacy of antidepressants for child and adolescent depression. PloS Med. 2006, 3: e9-CrossRefPubMed Raz A: Perspectives on the efficacy of antidepressants for child and adolescent depression. PloS Med. 2006, 3: e9-CrossRefPubMed
2.
go back to reference Wohlfarth T, Kalverdijk L, Rademarker C, Schothorst P, Minderaa R, Gispen-de Wied C: Psychopharmacology for children: from off label use to registration. Eur Neuropsychopharmacol. 2009, 19: 603-608. 10.1016/j.euroneuro.2009.04.007.CrossRefPubMed Wohlfarth T, Kalverdijk L, Rademarker C, Schothorst P, Minderaa R, Gispen-de Wied C: Psychopharmacology for children: from off label use to registration. Eur Neuropsychopharmacol. 2009, 19: 603-608. 10.1016/j.euroneuro.2009.04.007.CrossRefPubMed
3.
go back to reference Hammad TA, Laughren T, Racoosin J: Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006, 63: 332-339. 10.1001/archpsyc.63.3.332.CrossRefPubMed Hammad TA, Laughren T, Racoosin J: Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006, 63: 332-339. 10.1001/archpsyc.63.3.332.CrossRefPubMed
4.
go back to reference Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, Hammad TA, Temple R, Rochester G: Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ. 2009, 339: b2880-10.1136/bmj.b2880.CrossRefPubMedPubMedCentral Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, Hammad TA, Temple R, Rochester G: Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ. 2009, 339: b2880-10.1136/bmj.b2880.CrossRefPubMedPubMedCentral
5.
go back to reference Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA: Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007, 297: 1683-1696. 10.1001/jama.297.15.1683.CrossRefPubMed Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA: Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007, 297: 1683-1696. 10.1001/jama.297.15.1683.CrossRefPubMed
6.
go back to reference Hazell P, O'Connell D, Heathcote D, Henry D: Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev. 2002, CD002317- Hazell P, O'Connell D, Heathcote D, Henry D: Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev. 2002, CD002317-
7.
go back to reference Usala T, Clavenna A, Zuddas A, Bonati M: Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: A systematic review and meta-analysis. Eur Neuropsychopharmacol. 2008, 18: 62-73. 10.1016/j.euroneuro.2007.06.001.CrossRefPubMed Usala T, Clavenna A, Zuddas A, Bonati M: Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: A systematic review and meta-analysis. Eur Neuropsychopharmacol. 2008, 18: 62-73. 10.1016/j.euroneuro.2007.06.001.CrossRefPubMed
8.
go back to reference Cohen D, Deniau E, Maturana A, Tanguy ML, Bodeau N, Labelle R, Breton JJ, Guile JM: Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials. PLoS One. 2008, 3: e2632-10.1371/journal.pone.0002632.CrossRefPubMedPubMedCentral Cohen D, Deniau E, Maturana A, Tanguy ML, Bodeau N, Labelle R, Breton JJ, Guile JM: Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials. PLoS One. 2008, 3: e2632-10.1371/journal.pone.0002632.CrossRefPubMedPubMedCentral
9.
go back to reference Fraguas D, Correll CU, Merchán-Naranjo J, Rapado-Castro M, Parellada M, Moreno C, Arango C: Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons. Eur Neuropsychopharmacol. (in press) doi.org/10.1016/j.euroneuro.2010.07.002 Fraguas D, Correll CU, Merchán-Naranjo J, Rapado-Castro M, Parellada M, Moreno C, Arango C: Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons. Eur Neuropsychopharmacol. (in press) doi.org/10.1016/j.euroneuro.2010.07.002
10.
go back to reference Kapetanovic S, Simpson GM: Review of antipsychotics in children and adolescents. Expert Opin Pharmacother. 2006, 7: 1871-1885. 10.1517/14656566.7.14.1871.CrossRefPubMed Kapetanovic S, Simpson GM: Review of antipsychotics in children and adolescents. Expert Opin Pharmacother. 2006, 7: 1871-1885. 10.1517/14656566.7.14.1871.CrossRefPubMed
11.
go back to reference Jesner OS, Aref-Adib M, Coren E: Risperidone for autism spectrum disorder. Cochrane Database of Systematic Reviews. 2007, Art. No.: CD005040. DOI: 10.1002/14651858.CD005040.pub2, 1CrossRef Jesner OS, Aref-Adib M, Coren E: Risperidone for autism spectrum disorder. Cochrane Database of Systematic Reviews. 2007, Art. No.: CD005040. DOI: 10.1002/14651858.CD005040.pub2, 1CrossRef
12.
go back to reference Findling RL: Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents. J Clin Psychiatry. 2008, 69: 9-14. 10.4088/JCP.0308e09.CrossRefPubMed Findling RL: Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents. J Clin Psychiatry. 2008, 69: 9-14. 10.4088/JCP.0308e09.CrossRefPubMed
13.
go back to reference Kaiser J: Ethics. Private money, public disclosure. Science. 2009, 325 (5936): 28-30. 10.1126/science.325_28.CrossRefPubMed Kaiser J: Ethics. Private money, public disclosure. Science. 2009, 325 (5936): 28-30. 10.1126/science.325_28.CrossRefPubMed
14.
go back to reference Bonati M, Clavenna A: The epidemiology of psychotropic drug use in children and adolescents. Int Rev Psychiatry. 2005, 17: 181-188. 10.1080/09540260500093768.CrossRefPubMed Bonati M, Clavenna A: The epidemiology of psychotropic drug use in children and adolescents. Int Rev Psychiatry. 2005, 17: 181-188. 10.1080/09540260500093768.CrossRefPubMed
15.
go back to reference Zito JM, Safer DJ, de Jong-van den Berg LT, Janhsen K, Fegert JM, Gardner JF, Glaeske G, Valluri SC: A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health. 2008, 2: 26-10.1186/1753-2000-2-26.CrossRefPubMedPubMedCentral Zito JM, Safer DJ, de Jong-van den Berg LT, Janhsen K, Fegert JM, Gardner JF, Glaeske G, Valluri SC: A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health. 2008, 2: 26-10.1186/1753-2000-2-26.CrossRefPubMedPubMedCentral
16.
go back to reference Acquaviva E, Legleye S, Auleley GR, Deligne J, Carel D, Falissard B B: Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data. BMC Psychiatry. 2009, 17: 72-CrossRef Acquaviva E, Legleye S, Auleley GR, Deligne J, Carel D, Falissard B B: Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data. BMC Psychiatry. 2009, 17: 72-CrossRef
17.
go back to reference Zoëga H, Baldursson G, Hrafnkelsson B, Almarsdóttir AB, Valdimarsdóttir U, Halldórsson M: Psychotropic drug use among Icelandic children: a nationwide population-based study. J Child Adolesc Psychopharmacol. 2009, 19: 757-764. 10.1089/cap.2009.0003.CrossRefPubMed Zoëga H, Baldursson G, Hrafnkelsson B, Almarsdóttir AB, Valdimarsdóttir U, Halldórsson M: Psychotropic drug use among Icelandic children: a nationwide population-based study. J Child Adolesc Psychopharmacol. 2009, 19: 757-764. 10.1089/cap.2009.0003.CrossRefPubMed
18.
go back to reference Clavenna A, Rossi E, De Rosa M, Bonati M: Use of psychotropic medications in Italian children and adolescents. Eur J Pediatr. 2007, 166: 339-347. 10.1007/s00431-006-0244-7.CrossRefPubMed Clavenna A, Rossi E, De Rosa M, Bonati M: Use of psychotropic medications in Italian children and adolescents. Eur J Pediatr. 2007, 166: 339-347. 10.1007/s00431-006-0244-7.CrossRefPubMed
19.
go back to reference Clavenna A, Berti A, Gualandi L, Rossi E, De Rosa M, Bonati M: Drug utilisation profile in the Italian paediatric population. Eur J Pediatr. 2009, 168: 173-180. 10.1007/s00431-008-0725-y.CrossRefPubMed Clavenna A, Berti A, Gualandi L, Rossi E, De Rosa M, Bonati M: Drug utilisation profile in the Italian paediatric population. Eur J Pediatr. 2009, 168: 173-180. 10.1007/s00431-008-0725-y.CrossRefPubMed
20.
go back to reference Nardocci F: The birth of child and adolescent neuropsychiatry: from rehabilitation and social inclusion of the mentally handicapped, to the care of mental health during development. Ann Ist Super Sanità. 2009, 45: 33-38.PubMed Nardocci F: The birth of child and adolescent neuropsychiatry: from rehabilitation and social inclusion of the mentally handicapped, to the care of mental health during development. Ann Ist Super Sanità. 2009, 45: 33-38.PubMed
21.
go back to reference Percudani M, Barbui C, Fortino I, Petrovich L: Worrying patterns of out-patient psychotropic drug prescribing in children and adolescents. Psychother Psychosom. 2005, 74: 189-190. 10.1159/000084005.CrossRefPubMed Percudani M, Barbui C, Fortino I, Petrovich L: Worrying patterns of out-patient psychotropic drug prescribing in children and adolescents. Psychother Psychosom. 2005, 74: 189-190. 10.1159/000084005.CrossRefPubMed
22.
go back to reference Clavenna A, Bonati M: Antidepressant prescriptions in paediatric outpatients in Europe. Paediat Perinat Drug Ther. 2007, 8: 103-108. 10.1185/146300907X199911.CrossRef Clavenna A, Bonati M: Antidepressant prescriptions in paediatric outpatients in Europe. Paediat Perinat Drug Ther. 2007, 8: 103-108. 10.1185/146300907X199911.CrossRef
23.
go back to reference Olfson M, Marcus SC: National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009, 66: 848-856. 10.1001/archgenpsychiatry.2009.81.CrossRefPubMed Olfson M, Marcus SC: National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009, 66: 848-856. 10.1001/archgenpsychiatry.2009.81.CrossRefPubMed
24.
go back to reference Rani F, Murray ML, Byrne PJ, Wong IC: Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics. 2008, 121: 1002-1009. 10.1542/peds.2007-2008.CrossRefPubMed Rani F, Murray ML, Byrne PJ, Wong IC: Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics. 2008, 121: 1002-1009. 10.1542/peds.2007-2008.CrossRefPubMed
27.
go back to reference Gruppo di lavoro OSMED: L'uso dei farmaci in Italia. Rapporto nazionale anno 2008. 2009, Roma: Il Pensiero Scientifico Editore Gruppo di lavoro OSMED: L'uso dei farmaci in Italia. Rapporto nazionale anno 2008. 2009, Roma: Il Pensiero Scientifico Editore
28.
go back to reference Emslie, GJ, Ventura D, Korotzer A, Tourkodimitris S: Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry. 2009, 48: 721-729. 10.1097/CHI.0b013e3181a2b304.CrossRef Emslie, GJ, Ventura D, Korotzer A, Tourkodimitris S: Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry. 2009, 48: 721-729. 10.1097/CHI.0b013e3181a2b304.CrossRef
29.
go back to reference Wagner KD, Jonas J, Findling RL, Ventura D, Saikali K: A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry. 2006, 45: 280-288. 10.1097/01.chi.0000192250.38400.9e.CrossRefPubMed Wagner KD, Jonas J, Findling RL, Ventura D, Saikali K: A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry. 2006, 45: 280-288. 10.1097/01.chi.0000192250.38400.9e.CrossRefPubMed
30.
go back to reference National Institute of Clinical Excellence: Depression in children and young people. Identification and management in primary, community and secondary care. Clinical Guideline 28. (accessed 31 March 2011), [http://www.nice.org.uk/CG028] National Institute of Clinical Excellence: Depression in children and young people. Identification and management in primary, community and secondary care. Clinical Guideline 28. (accessed 31 March 2011), [http://​www.​nice.​org.​uk/​CG028]
31.
go back to reference Frigerio A, Rucci P, Goodman R, Ammaniti M, Carlet O, Cavolina P, De Girolamo G, Lenti C, Lucarelli L, Mani E, Martinuzzi A, Micali N, Milone A, Morosini P, Muratori F, Nardocci F, Pastore V, Polidori G, Tullini A, Vanzin L, Villa L, Walder M, Zuddas A, Molteni M: Prevalence and correlates of mental disorders among adolescents in Italy: The PrISMA study. Eur Child Adolesc Psychiatry. 2009, 18: 217-226. 10.1007/s00787-008-0720-x.CrossRefPubMed Frigerio A, Rucci P, Goodman R, Ammaniti M, Carlet O, Cavolina P, De Girolamo G, Lenti C, Lucarelli L, Mani E, Martinuzzi A, Micali N, Milone A, Morosini P, Muratori F, Nardocci F, Pastore V, Polidori G, Tullini A, Vanzin L, Villa L, Walder M, Zuddas A, Molteni M: Prevalence and correlates of mental disorders among adolescents in Italy: The PrISMA study. Eur Child Adolesc Psychiatry. 2009, 18: 217-226. 10.1007/s00787-008-0720-x.CrossRefPubMed
32.
go back to reference Didoni A, Costantino MA, Panei P, Clavenna A, Bonati M: Pharmacological treatment ADHD children of Lombardy Region (Italy) [abstract]. 12th ESDPPP Congress. June 17th to 20th Didoni A, Costantino MA, Panei P, Clavenna A, Bonati M: Pharmacological treatment ADHD children of Lombardy Region (Italy) [abstract]. 12th ESDPPP Congress. June 17th to 20th
33.
go back to reference Correll CU: Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. J Clin Psychiatry. 2008, 69 (Suppl 4): 26-36.PubMed Correll CU: Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. J Clin Psychiatry. 2008, 69 (Suppl 4): 26-36.PubMed
34.
go back to reference Jerrell JM, Hwang TL, Livingston TS: Neurological adverse events associated with antipsychotic treatment in children and adolescents. J Child Neurol. 2008, 23: 1392-1399. 10.1177/0883073808319070.CrossRefPubMed Jerrell JM, Hwang TL, Livingston TS: Neurological adverse events associated with antipsychotic treatment in children and adolescents. J Child Neurol. 2008, 23: 1392-1399. 10.1177/0883073808319070.CrossRefPubMed
35.
go back to reference Birmaher B, Axelson D, Goldstein B, Monk K, Kalas C, Obreja M, Hickey MB, Iyengar S, Brent D, Shamseddeen W, Diler R, Kupfer D: Psychiatric disorders in preschool offspring of parents with bipolar disorder: the Pittsburgh Bipolar Offspring Study (BIOS). Am J Psychiatry. 2010, 167: 321-330. 10.1176/appi.ajp.2009.09070977.CrossRefPubMedPubMedCentral Birmaher B, Axelson D, Goldstein B, Monk K, Kalas C, Obreja M, Hickey MB, Iyengar S, Brent D, Shamseddeen W, Diler R, Kupfer D: Psychiatric disorders in preschool offspring of parents with bipolar disorder: the Pittsburgh Bipolar Offspring Study (BIOS). Am J Psychiatry. 2010, 167: 321-330. 10.1176/appi.ajp.2009.09070977.CrossRefPubMedPubMedCentral
36.
go back to reference Verhulst FC, van der Ende J: Factors associated with child mental health service use in the community. J Am Acad Child Adolesc Psychiatry. 1997, 36: 901-909. 10.1097/00004583-199707000-00011.CrossRefPubMed Verhulst FC, van der Ende J: Factors associated with child mental health service use in the community. J Am Acad Child Adolesc Psychiatry. 1997, 36: 901-909. 10.1097/00004583-199707000-00011.CrossRefPubMed
Metadata
Title
Antidepressant and antipsychotic use in an Italian pediatric population
Authors
Antonio Clavenna
Margherita Andretta
Paola Pilati
Maurizio Dusi
Michele Gangemi
Maria Beatrice Gattoni
Giuseppe Lombardo
Leonardo Zoccante
Luigi Mezzalira
Maurizio Bonati
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2011
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/1471-2431-11-40

Other articles of this Issue 1/2011

BMC Pediatrics 1/2011 Go to the issue